ITMCTR2200006549
Recruiting
未知
A controlled clinical study to evaluate the efficacy of Tibetan medicine in the prevention and treatment of asymptomatic COVID-19 infection and mild COVID-19 patients
Tibetan Hospital Mentsee Khang of Tibet Autonomous Region0 sitesTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Tibetan Hospital Mentsee Khang of Tibet Autonomous Region
- Status
- Recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Meet the novel coronavirus diagnostic criteria for asymptomatic infection
- •Tibetan Medicine Diagnosis and Treatment Plan for COVID\-19 in Tibet Autonomous Region (trial version 3\).
- •The COVID\-19 nucleic acid test was positive. No clinical manifestations or imaging manifestations of pneumonia.
- •2\. Meet the novel coronavirus diagnostic criteria for mild coronavirus;
- •Mild cases may present with fever, dry cough, headache, sore throat, etc. The clinical symptoms were mild, and imaging showed no signs of pneumonia.
- •2\.1 General Inspection
- •In the early stage of the disease, the total number of peripheral blood white blood cells is normal or decreased, and the lymphocyte count is decreased. Some patients may have increased liver enzymes, lactate dehydrogenase, muscle enzymes, myoglobin, troponin and ferritin. C\-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) were elevated in most patients, while procalcitonin (PCT) was normal. In severe and critical patients, D\-dimer increased, peripheral blood lymphocytes decreased progressively, and inflammatory factors increased.
- •2\.2 Etiological and serological examination
- •2\.2\.1 Pathogenic examination: Test novel coronavirus nucleic acid on nose and oropharyngeal swabs, sputum and other lower respiratory tract secretions, and feces by nucleic acid amplification test. Nucleic acid detection will be affected by the course of disease, specimen collection, detection process, detection reagents and other factors. In order to improve the accuracy of detection, the collection of specimens should be standardized, and specimens should be submitted to test as soon as possible after collection.
- •2\.2\.2 Serological examination: novel coronavirus specific IgM and IgG antibodies are positive, and the positive rate within 1 week after onset is low.
Exclusion Criteria
- •1\. Patients with serious diseases of heart, brain, liver, kidney and hematopoietic system;
- •2\. Allergic constitution or allergic to a variety of drugs.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 2
Avabahuka management through ayurvedaHealth Condition 1: M958- Other specified acquired deformities of musculoskeletal systemCTRI/2024/03/063989Pt Khushilal Sharma Government Autonomous Ayurveda College and Institute Bhopal MP
Not yet recruiting
Phase 3
A comparitive clinical study of povidine ointment and Vranaropani malahara on fresh woundCTRI/2024/07/069772Dr Surender Redhu
Completed
Phase 2
management of plantar fasciitis by ayurvedic kwath iontophoresisHealth Condition 1: M709- Unspecified soft tissue disorder related to use, overuse and pressureCTRI/2021/05/033429All India Institute of Ayurveda25
Not yet recruiting
Phase 3
To study the effect of Jatyadighrita suppository and Diclofenac suppository in managing the pain after surgery in Anorectal disordersHealth Condition 1: T889- Complication of surgical and medical care, unspecifiedCTRI/2022/09/046069Dr SRINIVASA N V
Not yet recruiting
Phase 2
A clinical study to evaluate the efficacy of Nirgundi taila and Nirgundi malahara in the management of Fissure-in-anoCTRI/2023/12/060815Dr Hari R